Treatment tapering in oligoarticular or rheumatoid factor negative polyarticular Juvenile Idiopathic Arthritis with inactive disease on biologic therapy
Latest Information Update: 02 Nov 2021
At a glance
- Drugs Abatacept (Primary) ; Adalimumab (Primary) ; Etanercept (Primary) ; Tocilizumab (Primary)
- Indications Juvenile rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms AJIBIOREM
- 15 Oct 2020 New trial record